Correlation between Density of CD8+ T-cell Infiltrate in Microsatellite Unstable Colorectal Cancers and Frameshift Mutations: A Rationale for Personalized Immunotherapy

Archive ouverte

Maby, Pauline | Tougeron, David | Hamieh, Mohamad | Mlecnik, Bernhard | Kora, Hafid | Bindea, Gabriela | Angell, Helen K. | Fredriksen, Tessa | Elie, Nicolas | Fauquembergue, Emilie | Drouet, Aurélie | Leprince, Jérôme | Benichou, Jacques | Mauillon, Jacques | Le Pessot, Florence | Sesboüe, Richard | Tuech, Jean-Jacques | Sabourin, Jean-Christophe | Michel, Pierre | Frebourg, Thierry | Galon, Jérôme | Latouche, Jean-Baptiste

Edité par CCSD ; American Association for Cancer Research -

International audience. Colorectal cancers with microsatellite instability (MSI) represent 15% of all colorectal cancers, including Lynch syndrome as the most frequent hereditary form of this disease. Notably, MSI colorectal cancers have a higher density of tumor-infiltrating lymphocytes (TIL) than other colorectal cancers. This feature is thought to reflect the accumulation of frameshift mutations in sequences that are repeated within gene coding regions, thereby leading to the synthesis of neoantigens recognized by CD8(+) T cells. However, there has yet to be a clear link established between CD8(+) TIL density and frameshift mutations in colorectal cancer. In this study, we examined this link in 103 MSI colorectal cancers from two independent cohorts where frameshift mutations in 19 genes were analyzed and CD3(+), CD8(+), and FOXP3(+) TIL densities were quantitated. We found that CD8(+) TIL density correlated positively with the total number of frameshift mutations. TIL densities increased when frameshift mutations were present within the ASTE1, HNF1A, or TCF7L2 genes, increasing even further when at least one of these frameshift mutations was present in all tumor cells. Through in vitro assays using engineered antigen-presenting cells, we were able to stimulate peripheral cytotoxic T cells obtained from colorectal cancer patients with peptides derived from frameshift mutations found in their tumors. Taken together, our results highlight the importance of a CD8(+) T cell immune response against MSI colorectal cancer-specific neoantigens, establishing a preclinical rationale to target them as a personalized cellular immunotherapy strategy, an especially appealing goal for patients with Lynch syndrome.

Consulter en ligne

Suggestions

Du même auteur

Orexigenic Neuropeptide 26RFa: New Evidence for an Adaptive Profile of Appetite Regulation in Anorexia Nervosa

Archive ouverte | Fauquembergue, Emilie | CCSD

International audience. Restrictive anorexia nervosa (AN) presents an adaptive appetite regulating profile including mainly high levels of ghrelin. Because this adaptive mechanism is not effective on food intake, ot...

HLA-A*0201-restricted CEA-derived peptide CAP1 is not a suitable target for T-cell-based immunotherapy.

Archive ouverte | Fauquembergue, Emilie | CCSD

International audience. Carcinoembryonic antigen (CEA) is a potential target for antigen-specific immunotherapy, as it is frequently overexpressed in human carcinomas. Moreover, an epitope derived from CEA, designat...

Artificial antigen-presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4 + T cells

Archive ouverte | Garnier, Anthony | CCSD

International audience. Owing to their multiple immune functions, CD4(+) T cells are of major interest for immunotherapy in chronic viral infections and cancer, as well as for severe autoimmune diseases and transpla...

Chargement des enrichissements...